298380.KQ
ABL Bio Inc. [298380.KQ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
298380.KQ Stock Summary
Top 10 Correlated ETFs
298380.KQ
Top 10 Correlated Stocks
298380.KQ
In the News
298380.KQ Financial details
Company Rating
-
Market Cap
853.06B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
13 Nov 2023
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
4.7%
SMA50
0.23%
SMA100
-12.05%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
45.3M
Shs Float
29.06M
-
-
-
-
Target Price
-
52W Range
17050.0-26900.0
52W High
-29.52%
52W Low
+11.2%
RSI
50
Rel Volume
0.37
Avg Volume
471.28K
Volume
175.19K
Perf Week
-2.72%
Perf Month
2.49%
Perf Quarter
-24.31%
Perf Half Y
-9.06%
-
-
-
-
Beta
0.804181
-
-
Volatility
256.44%, 861.77%
Prev Close
0%
Price
18960
Change
3.49%
Company Profile
- Volume Average 471.28K
- Market Capitalization 853.06B
- CEO Dr. Sang Hoon Lee Ph.D.
- Headquarters Seongnam,KR
- IPO Date 2018-12-19
-
Website
http://www.ablbio.com 
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. The company is headquartered in Seongnam, South Korea.
